{"disease":{"id":"rift-valley-fever","name":"rift valley fever"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT05139524","title":"RVF and Other Emerging Infectious Diseases in East and Central Africa","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Washington State University","has_results":false},{"nct_id":"NCT06799234","title":"Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":240,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT04672824","title":"A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT04754776","title":"Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"University of Oxford","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}